Prediction of tumor recurrence by α-fetoprotein model after curative resection for hepatocellular carcinoma.

[1]  I. Endo,et al.  Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria , 2020, Annals of Surgical Oncology.

[2]  [Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)]. , 2020 .

[3]  A. Villanueva,et al.  Biomarkers for Hepatobiliary Cancers , 2020, Hepatology.

[4]  Francesca Ratti,et al.  Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines , 2019, Annals of Surgical Oncology.

[5]  Sheng-Nan Lu,et al.  Predictive Effects of Inflammatory Scores in Patients with BCLC 0-A Hepatocellular Carcinoma after Hepatectomy , 2019, Journal of clinical medicine.

[6]  I. Endo,et al.  Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification , 2019, Annals of Surgical Oncology.

[7]  A. Villanueva.  Hepatocellular Carcinoma. , 2019, The New England journal of medicine.

[8]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[9]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[10]  Yaming Li,et al.  Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition) , 2018, Liver Cancer.

[11]  K. Nan,et al.  Surgical resection improves long-term survival of patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages , 2017, Cancer management and research.

[12]  F. Roudot-thoraval,et al.  Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC. , 2017, Journal of hepatology.

[13]  J. H. Kim,et al.  Survival Analysis of Single Large (>5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B , 2016, PloS one.

[14]  H. Eguchi,et al.  Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinoma. , 2016, Surgery.

[15]  M. Schwartz,et al.  Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. , 2015, Annals of surgery.

[16]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[17]  G. Spolverato,et al.  Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. , 2015, Journal of hepatology.

[18]  H. Schulze‐Bergkamen,et al.  Survival analysis of proposed BCLC‐B subgroups in hepatocellular carcinoma patients , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[19]  Y. Imai,et al.  JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan , 2014, Liver Cancer.

[20]  S. Fan,et al.  Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. , 2014, Gastroenterology.

[21]  V. Mazzaferro,et al.  Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions , 2012, Seminars in Liver Disease.

[22]  F. Roudot-thoraval,et al.  Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. , 2012, Gastroenterology.

[23]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[24]  G. Torzilli,et al.  Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis. , 2008, Archives of surgery.

[25]  Joris R Delanghe,et al.  Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[26]  Sheng-Nan Lu,et al.  The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients. , 2008, European journal of cancer.

[27]  J. Marrero.  Staging systems for hepatocellular carcinoma: should we all use the BCLC system? , 2006, Journal of hepatology.

[28]  Alessandro Vitale,et al.  Prospective validation of the Barcelona Clinic Liver Cancer staging system. , 2006, Journal of hepatology.

[29]  J. Marrero,et al.  Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort , 2005, Hepatology.

[30]  A. Burroughs,et al.  Hepatocellular carcinoma , 2003, The Lancet.

[31]  A. Gardini,et al.  Liver Resection for Hepatocellular Carcinoma on Cirrhosis: Univariate and Multivariate Analysis of Risk Factors for Intrahepatic Recurrence , 2003, Annals of surgery.

[32]  A. Befeler,et al.  Hepatocellular carcinoma: diagnosis and treatment. , 2002, Gastroenterology.

[33]  J. Bruix,et al.  Prognostic prediction and treatment strategy in hepatocellular carcinoma , 2002, Hepatology.

[34]  M. Kojiro,et al.  Immunohistologic study on the expressions of α‐fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma , 2001, Hepatology.

[35]  Riccardo Lencioni,et al.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. , 2012, Journal of hepatology.

[36]  Alessandro Vitale,et al.  The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? , 2004, Journal of hepatology.